Amneal Pharmaceuticals LLC announced appointment of Rochelle Fuhrmann as Chief Financial Officer. Ms. Fuhrmann was most recently Senior Vice President, Finance at Warner Chilcott plc.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.485 USD | +0.70% | -4.62% | +7.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.17% | 1.99B | |
+38.78% | 728B | |
+33.05% | 603B | |
-6.32% | 360B | |
+18.63% | 332B | |
+1.01% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.17% | 164B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals LLC Appoints Rochelle Fuhrmann as Chief Financial Officer